Table 3

Unadjusted mean (SD) change in BCVA by baseline DRSS score at week 52 and week 100

Week 52Week 100
Laser
(n=249)
Intravitreal aflibercept
(n=499)
Laser
(n=249)
Intravitreal aflibercept
(n=499)
Low risk
(DRSS ≤43)
1.3 (11.2)10.3 (8.7)1.3 (11.6)10.2 (10.7)
Moderate risk
(DRSS =47)
0.0 (12.7)10.0 (6.7)0.5 (14.5)10.2 (10.5)
High risk
(DRSS ≥53)
0.5 (11.3)12.8 (9.5)0.9 (12.9)12.1 (12.7)
  • Only those with gradable baseline DRSS scores are included.

  • BCVA, best-corrected visual acuity; DRSS, Diabetic Retinopathy Severity Scale.